Hexachlorophene preparations in infant antiseptic skin care: benefits, risks, and the future.
D000287:Administration, Topical; D001315:Australia; D002490:Central Nervous System / Q000187:drug effects / Q000473:pathology; D003428:Cross Infection / Q000517:prevention & control*; D003872:Dermatitis / Q000517:prevention & control*; D004341:Drug Evaluation; D004655:Emulsions; D006582:Hexachlorophene / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity; D006771:Hospitals, Maternity; D006801:Humans; D007224:Infant Care; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000517:prevention & control*; D011208:Powders; D012306:Risk; D013203:Staphylococcal Infections / Q000517:prevention & control*
D004655:Emulsions; D011208:Powders; D006582:Hexachlorophene